TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17107904

Group type: EXPERIMENTAL
Intervention: Chlorambucil 20 mg m‐2 for 3 days and dexamethasone 4 mg bd for 5 days plus oral idarubicin 10 mg m‐2 for 3 days (CID)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Chlorambucil 20 mg m‐2 for 3 days and dexamethasone 4 mg bd for 5 days (CD)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CID
Number of subjects: 200

Group type: COMPARATOR
Intervention: CD
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CID (B‐cell follicular group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: CD (B‐cell follicular group)
Number of subjects: 200
Study: 14735364

Group type: EXPERIMENTAL
Intervention: Elderly group (70-79 years)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Younger group (20-29 years)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Women (elderly)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Men (elderly)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Women (younger)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Men (younger)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Elderly women
Number of subjects: 194
Study: 11768840

Group type: EXPERIMENTAL
Intervention: Cefprozil (15 mg/kg per day in 2 divided doses for 10 days)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Erythromycin (30 mg/kg per day in 3 divided doses for 10 days)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 199
Study: 9407447

Group type: EXPERIMENTAL
Intervention: Benazepril
Number of subjects: 0
Study: 8500921

Group type: EXPERIMENTAL
Intervention: Nocloprost (400 micrograms)
Number of subjects: 16
Study: 3307308

Group type: EXPERIMENTAL
Intervention: Metoprolol (3.0 mg i.v. bolus followed by an i.v. infusion of 4.8 mg/h)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Insulin (2.4 U/h i.v. infusion over 180 min)
Number of subjects: 8
Study: 31702602

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT) and telephone counseling
Number of subjects: 92

Group type: COMPARATOR
Intervention: Telephone counseling alone
Number of subjects: 92
Study: 28004473

Group type: EXPERIMENTAL
Intervention: Walking programme (Walk Well)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Self-monitoring (using pedometer and diary)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Role of carers
Number of subjects: 19
Study: 27801789

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 24473376

Group type: EXPERIMENTAL
Intervention: Clinical pathway of health education
Number of subjects: 116

Group type: COMPARATOR
Intervention: Traditional health education
Number of subjects: 116
Study: 23683751

Group type: EXPERIMENTAL
Intervention: MAL-PDT (methylaminolevulinate photodynamic therapy; two sessions with an interval of 1 week)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Imiquimod cream (once daily, five times a week for 6 weeks)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Fluorouracil cream (twice daily for 4 weeks)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Imiquimod vs MAL-PDT
Number of subjects: 601

Group type: COMPARATOR
Intervention: Fluorouracil vs MAL-PDT
Number of subjects: 601

Group type: COMPARATOR
Intervention: Fluorouracil vs Imiquimod
Number of subjects: 601
Study: 19957035

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily
Number of subjects: 780
Study: 18727125

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (angioplasty)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study: 16083385

Group type: EXPERIMENTAL
Intervention: Korean MMPI-2 F, Fb, F-K, and F(p) scales
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Korean MMPI-2 L, K, and S scales
Number of subjects: 0
Study: 12161831

Group type: EXPERIMENTAL
Intervention: Pelvic tilt exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Abdominal hollowing exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Trunk stability test (TST) exercise
Number of subjects: 14
Study: 10382464

Group type: EXPERIMENTAL
Intervention: Home apnea monitors (used by 52 parents)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Non-monitored group (52 parents)
Number of subjects: 104
Study: 7675553

Group type: EXPERIMENTAL
Intervention: Postural drainage (PD)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure physiotherapy (PEP)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-frequency chest compression physiotherapy (HFCC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control treatment (CONT)
Number of subjects: 16
Study: 1974429

Group type: EXPERIMENTAL
Intervention: Flutoprazepam 4 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Flutoprazepam 2 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 7323625

Group type: EXPERIMENTAL
Intervention: Tiapride (300 mg/day orally for 30 days)
Number of subjects: 50
Study: 31865235

Group type: EXPERIMENTAL
Intervention: Multiple Exposure treatment condition (at least 15 activities, exposed once)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Repeated Exposure treatment condition (3 activities, exposed during five sessions each)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Multiple Exposure treatment condition
Number of subjects: 8
Study: 30182286

Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate (SB)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: BA + SB (BASB)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 71

Group type: COMPARATOR
Intervention: BA
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 71
Study: 28703931

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 66

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 66
Study: 25592159

Group type: EXPERIMENTAL
Intervention: Suicide Risk Management Protocol (SRMP)
Number of subjects: 302
Study: 24337659

Group type: EXPERIMENTAL
Intervention: Desflurane (4-7 vol%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol (2-3.5 μg/ml)
Number of subjects: 40
Study: 23174584

Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin
Number of subjects: 180

Group type: COMPARATOR
Intervention: Regular dose atorvastatin
Number of subjects: 180
Study: 19999921

Group type: EXPERIMENTAL
Intervention: Fast track group (epidural analgesia, early ambulation, oral feeding)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no epidural analgesia, early ambulation, early oral diet)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fast track group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 16889491

Group type: EXPERIMENTAL
Intervention: T(4) treatment in DS infants (N = 99)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo treatment in DS infants (N = 97)
Number of subjects: 196
Study: 12963912

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1%
Number of subjects: 19

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 19
Study: 10378525

Group type: EXPERIMENTAL
Intervention: Electrocautery
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Laser cautery
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Submucosal resection without lateral displacement
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Submucosal resection with lateral displacement
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Turbinectomy
Number of subjects: 382
Study: 8721797

Group type: EXPERIMENTAL
Intervention: Blind assessments by 7 raters
Number of subjects: 36

Group type: COMPARATOR
Intervention: Open assessments by 7 raters
Number of subjects: 36
Study: 1818603

Group type: EXPERIMENTAL
Intervention: Dequalinium chloride
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sanguinarine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 6
Study: 6668603

Group type: EXPERIMENTAL
Intervention: Fifteen session psychosocial smoking prevention strategy
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Booster sessions conducted during the year after completion of the program
Number of subjects: 902
Study: 30341035

Group type: EXPERIMENTAL
Intervention: High-Efficiency Hemodialysis (HEHD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Postdilution Hemodiafiltration (HDFpost)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Predilution Hemodiafiltration (HDFpre)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-Efficiency Hemodialysis (HEHD), Postdilution Hemodiafiltration (HDFpost), Predilution Hemodiafiltration (HDFpre)
Number of subjects: 10
Study: 29775087

Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26462702

Group type: EXPERIMENTAL
Intervention: ILR alone
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: SC alone
Number of subjects: 246

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: SC + ILR
Number of subjects: 246
Study: 24075141

Group type: EXPERIMENTAL
Intervention: Gluten- and casein-free diet
Number of subjects: 0
Study: 23132262

Group type: EXPERIMENTAL
Intervention: General anesthesia and TAP block (Group T)
Number of subjects: 68

Group type: COMPARATOR
Intervention: General anesthesia alone (Group G)
Number of subjects: 68
Study: 21111365

Group type: EXPERIMENTAL
Intervention: Tenecteplase (up to 2 mg) administered intraluminally, with a second dose if indicated and a third placebo dose.
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo followed by up to two doses of tenecteplase if needed.
Number of subjects: 97
Study: 18078506

Group type: EXPERIMENTAL
Intervention: Knee arthroscopy and an 8‐week home exercise program
Number of subjects: 56

Group type: COMPARATOR
Intervention: 8‐week home exercise program only (Control)
Number of subjects: 56
Study: 15675979

Group type: EXPERIMENTAL
Intervention: Amino acids (500 ml intravenously during 4 h)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Ringer's solution (500 ml intravenously during 4 h)
Number of subjects: 34
Study: 12166794

Group type: EXPERIMENTAL
Intervention: Triple dye once followed by daily alcohol application
Number of subjects: 634

Group type: COMPARATOR
Intervention: Daily alcohol application alone
Number of subjects: 634
Study: 10214005

Group type: EXPERIMENTAL
Intervention: Mild hypothermia (34.5 degrees C)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Normothermia (36.0 degrees C)
Number of subjects: 173
Study: 7885622

Group type: EXPERIMENTAL
Intervention: Diet high in monounsaturated fat and low in carbohydrate
Number of subjects: 0
Study: 2281848

Group type: EXPERIMENTAL
Intervention: Midazolam (0.2-0.3 mg/kg b.w. i.v., group I n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diazepam (0.3-0.4 mg/kg b.w., i.v., group II n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (0.03-0.04 mg/kg b.w., i.v., group III n = 10)
Number of subjects: 30
Study: 484256

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (untreated hyperthyroid)
Number of subjects: 20
Study: 30987765

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lung sliding sign
Number of subjects: 74

Group type: COMPARATOR
Intervention: Auscultation
Number of subjects: 74
Study: 27494272

Group type: EXPERIMENTAL
Intervention: Tip cryotherapy
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 101
Study: 26672085

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Topotecan
Number of subjects: 452
Study: 23890856

Group type: EXPERIMENTAL
Intervention: Fish oil (total omega-3 6 g/d)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control
Number of subjects: 78

Group type: COMPARATOR
Intervention: Crossover group (21 fish oil patients who crossed over to control)
Number of subjects: 78
Study: 21532464

Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 213

Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 213
Study: 19246952

Group type: EXPERIMENTAL
Intervention: Daily oral intake of 300 mg alpha‐tocopheryl‐acetate for 2 months
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 39
Study: 16987583

Group type: EXPERIMENTAL
Intervention: Biphasic (Welch Allyn‐MRL PIC; 70, 100, 150, 200 and 300J)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Monophasic (Hewlett Packard Codemaster XL; 100, 200, 300, 360 and 360J)
Number of subjects: 139
Study: 14529975

Group type: EXPERIMENTAL
Intervention: Isotretinoin A for chemoprevention of second primary tumors
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Surgical resection for SPLC
Number of subjects: 569

Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 569

Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 569
Study: 10753003

Group type: EXPERIMENTAL
Intervention: Sleep restriction therapy combined with sleep hygiene
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nap modification of sleep restriction therapy combined with sleep hygiene
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sleep hygiene alone
Number of subjects: 39
Study: 8631189

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (naringin, 887 mg/ml)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Herbal tea
Number of subjects: 13
Study: 1420493

Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine premixed dialysis solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control dialysis solution
Number of subjects: 12
Study: 6703415

Group type: EXPERIMENTAL
Intervention: Budesonide nasal spray
Number of subjects: 60

Group type: COMPARATOR
Intervention: Flunisolide nasal spray
Number of subjects: 60
Study: 31451013

Group type: EXPERIMENTAL
Intervention: everolimus-eluting drug-eluting stents (DES)
Number of subjects: 1498

Group type: COMPARATOR
Intervention: bare-metal stents (BMS)
Number of subjects: 1498
Study: 28467737

Group type: EXPERIMENTAL
Intervention: 12-week resistance training programme
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 27455961

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 354

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 354
Study: 24585000

Group type: EXPERIMENTAL
Intervention: Postpartum oxytocin infusion of 80 U/500 mL over 1 hour
Number of subjects: 1329

Group type: COMPARATOR
Intervention: Postpartum oxytocin infusion of 80 U/500 mL over 8 hours
Number of subjects: 1329
Study: 22798287

Group type: EXPERIMENTAL
Intervention: Physical activity programme (experimental group)
Number of subjects: 70
Study: 20673141

Group type: EXPERIMENTAL
Intervention: Acupuncture at ST 36
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Acupuncture at ST 36 plus PC 6
Number of subjects: 15

Group type: COMPARATOR
Intervention: Acupuncture at PC 6
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 15
Study: 17331928

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (US)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Combined ultrasound and nerve stimulation (USNS)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Nerve stimulation (NS)
Number of subjects: 188
Study: 16375199

Group type: EXPERIMENTAL
Intervention: Inhaled short-acting beta2 agonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine spirometric reversibility testing
Number of subjects: 0
Study: 12226605

Group type: COMPARATOR
Intervention: Control group with no treatment
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pumice-laser (pumiced for 3 seconds and treated with a 325 mW, 5-mm diameter laser beam for 60 seconds)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pumice-etch-laser (pumiced for 3 seconds, acid-etched with 30% phosphoric acid for 30 seconds, and treated for 60 seconds with laser)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Laser only (treated for 60 seconds with laser)
Number of subjects: 9
Study: 11150453

Group type: EXPERIMENTAL
Intervention: Predictive equation using birth weight and 5-minute Apgar scores
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: High, intermediate, and low risk stratification based on birth weight and Apgar scores
Number of subjects: 1054
Study: 9839347

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study: 7951277

Group type: EXPERIMENTAL
Intervention: Treatment group (with side effects)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group (without side effects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment noncompliers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypothetical scenario with treatment compliance equal to placebo compliance
Number of subjects: 0
Study: 3282478

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 526

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 526
Study: 29273873

Group type: EXPERIMENTAL
Intervention: Video review group
Number of subjects: 16

Group type: COMPARATOR
Intervention: No video review group
Number of subjects: 16
Study: 27085769

Group type: EXPERIMENTAL
Intervention: fasted-state HIIE (HIIEfast)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HIIE
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: fasted-state exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: MICE
Number of subjects: 10

Group type: COMPARATOR
Intervention: no exercise (control)
Number of subjects: 10
Study: 25614598

Group type: EXPERIMENTAL
Intervention: Endurance training (T)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Training and increased caloric intake (T-iD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diet (D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 60
Study: 23510037

Group type: EXPERIMENTAL
Intervention: 2.0 mg ranibizumab, treated as needed every 4 weeks (cohort A)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 2.0 mg ranibizumab, treated as needed every 6 weeks (cohort B)
Number of subjects: 88
Study: 21279645

Group type: EXPERIMENTAL
Intervention: Wheat flour inhalation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Rye flour inhalation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 25
Study: 17620665

Group type: EXPERIMENTAL
Intervention: Encouragement by family and/or friends (social network characteristic)
Number of subjects: 1475

Group type: EXPERIMENTAL
Intervention: Subjective norms (social network characteristic)
Number of subjects: 1475

Group type: EXPERIMENTAL
Intervention: Perception that screening was normative (social network characteristic)
Number of subjects: 1475
Study: 16303790

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal intervention (MI)
Number of subjects: 0
Study: 12749482

Group type: EXPERIMENTAL
Intervention: Insecticide-treated bed nets (ITNs)
Number of subjects: 1722

Group type: COMPARATOR
Intervention: Control (no ITNs)
Number of subjects: 1722

Group type: EXPERIMENTAL
Intervention: Insecticide-treated bed nets (ITNs) re-treated every six months
Number of subjects: 1722
Study: 10947754

Group type: COMPARATOR
Intervention: Flexiblade laryngoscope with lever in neutral position
Number of subjects: 200

Group type: COMPARATOR
Intervention: Flexiblade laryngoscope with lever depressed
Number of subjects: 200

Group type: COMPARATOR
Intervention: Flexiblade laryngoscope
Number of subjects: 200
Study: 8638833

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 63
Study: 1593216

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg two times a day) with dimethyl sulfoxide (500 mg four times daily)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg two times a day) with allopurinol (50 mg four times a day)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Cimetidine (400 mg two times a day)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Cimetidine (400 mg at bedtime)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg two times a day) with dimethyl sulfoxide or allopurinol
Number of subjects: 169
Study: 29193877

Group type: EXPERIMENTAL
Intervention: Probiotic treatment for 10 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (placebo) for 10 days
Number of subjects: 80
Study: 26525804

Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (RA) followed by stenting
Number of subjects: 240

Group type: COMPARATOR
Intervention: Stenting without RA (control)
Number of subjects: 240
Study: 25019115

Group type: EXPERIMENTAL
Intervention: Honey applied four times a day for 5 days
Number of subjects: 94

Group type: COMPARATOR
Intervention: Topical corticosteroid
Number of subjects: 94

Group type: COMPARATOR
Intervention: Orabase treatment
Number of subjects: 94
Study: 23449351

Group type: EXPERIMENTAL
Intervention: FOLFOX/XELOX plus cediranib 20 mg (HORIZON II)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: mFOLFOX6 plus cediranib 20 mg (HORIZON III)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Placebo (HORIZON II)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Bevacizumab (HORIZON III)
Number of subjects: 2000
Study: 19898259

Group type: EXPERIMENTAL
Intervention: Docetaxel/cisplatin/fluorouracil (TPF) combination chemotherapy
Number of subjects: 39
Study: 18375612

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No inhaled nitric oxide (no iNO)
Number of subjects: 108
Study: 17045905

Group type: EXPERIMENTAL
Intervention: 40 g walnuts
Number of subjects: 24

Group type: COMPARATOR
Intervention: 25 g olive oil
Number of subjects: 24
Study: 12781165

Group type: EXPERIMENTAL
Intervention: Exposure group (daily tasting of the target vegetable for 14 days)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Information group (nutritional advice and leaflet)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (no further intervention)
Number of subjects: 156
Study: 11220442

Group type: EXPERIMENTAL
Intervention: Covariational causes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Goal-based causes
Number of subjects: 0